BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9745257)

  • 1. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
    Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of dynamic susceptibility contrast MRI using echo-planar imaging in differential diagnosis of breast tumors].
    Yoshino A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):441-6. PubMed ID: 9745258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of contrast-enhanced breast MR imaging.
    Piccoli CW
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):557-71. PubMed ID: 7489308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic fibrous mastopathy: dynamic contrast-enhanced magnetic resonance imaging findings.
    Tuncbilek N; Karakas HM; Okten O
    Breast J; 2004; 10(4):359-62. PubMed ID: 15239797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
    Orel SG; Schnall MD; LiVolsi VA; Troupin RH
    Radiology; 1994 Feb; 190(2):485-93. PubMed ID: 8284404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of fine needle aspiration biopsy for breast fibroadenoma diagnosis.
    Szylberg T; Sygut J; Kulig A
    Pol J Pathol; 1997; 48(2):79-86. PubMed ID: 9278103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
    Nishiura M; Yasuhiro T; Murase K
    Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences].
    Dannert S; Krück W; Schick F; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Jan; 173(1):38-43. PubMed ID: 11225415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ability of subtraction and dynamic MR imaging to detect breast tumors: comparison with ultrasonography and mammography].
    Terao E; Takeuchi H; Iwamura A; Murakami Y; Harada J; Tada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):950-7. PubMed ID: 7971186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of time-to-peak analysis for differentiating malignant and benign breast lesions with dynamic contrast-enhanced MRI.
    Liu F; Kornecki A; Shmuilovich O; Gelman N
    Acad Radiol; 2011 Jun; 18(6):694-704. PubMed ID: 21420329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
    Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
    Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibroadenoma of the breast: a case report.
    Durak MG; Karaman I; Canda T; Balci P; Harmancioğlu O
    Turk Patoloji Derg; 2011; 27(3):254-6. PubMed ID: 21935877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer].
    Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH
    Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of the human female breast. Current status and pathologic correlations.
    Powell DE; Stelling CB
    Pathol Annu; 1988; 23 Pt 1():159-94. PubMed ID: 2838793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS; Tse GM; Lai SY; Yeung DK
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat-suppressed three-dimensional MR imaging of the breast.
    Harms SE; Flamig DP; Hesley KL; Evans WP; Cheek JH; Peters GN; Knox SM; Savino DA; Netto GJ; Wells RB
    Radiographics; 1993 Mar; 13(2):247-67. PubMed ID: 8460218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.